Gilad Rosenberg
Keine laufenden Positionen mehr
Profil
Gilad Rosenberg worked as a Medical Director at Clal Biotechnology Industries Ltd.
and Organon Pharma (UK) Ltd.
He then worked as Vice President-Clinical Development at Univo Pharmaceuticals Ltd.
from 2000 to 2016.
Rosenberg received an undergraduate degree from Technion-Israel Institute of Technology in 1992 and a graduate degree from the University of Oxford in 2005.
Ehemalige bekannte Positionen von Gilad Rosenberg
| Unternehmen | Position | Ende |
|---|---|---|
| UNIVO PHARMACEUTICALS LTD | Corporate Officer/Principal | 07.05.2016 |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Gilad Rosenberg
| Technion-Israel Institute of Technology | Undergraduate Degree |
| University of Oxford | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNIVO PHARMACEUTICALS LTD | Health Technology |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| Private Unternehmen | 1 |
|---|---|
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
